Literature DB >> 19263183

Hemolytic uremic syndrome and pericarditis as early manifestations of primary Sjögren's syndrome.

Hung-An Chen1, Chun-Hsiung Chen, He-Hsiung Cheng.   

Abstract

Hemolytic uremic syndrome (HUS) consists of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. Autoimmune diseases have seldom been reported to be the etiology of HUS. Primary Sjögren's syndrome (pSS) is a systemic autoimmune disease affecting primarily the exocrine glands. Symptomatic pericarditis and pulmonary hemorrhage are rare manifestations in pSS patients. We describe the unusual case of a pSS patient with the initial presentation of HUS and pericarditis and a fatal progression of pulmonary hemorrhage. A renal biopsy established the diagnosis of HUS with histologically proven arterial thrombotic microangiopathy and glomerular and tubular ischemic necrosis. The relationships between HUS and pericarditis and pSS will be discussed in this report.

Entities:  

Mesh:

Year:  2009        PMID: 19263183     DOI: 10.1007/s10067-009-1121-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Clinical and morphological features of kidney involvement in primary Sjögren's syndrome.

Authors:  N Bossini; S Savoldi; F Franceschini; S Mombelloni; M Baronio; I Cavazzana; B F Viola; B Valzorio; C Mazzucchelli; R Cattaneo; F Scolari; R Maiorca
Journal:  Nephrol Dial Transplant       Date:  2001-12       Impact factor: 5.992

Review 2.  Kidney injury in Sjögren's syndrome.

Authors:  F N Skopouli
Journal:  Nephrol Dial Transplant       Date:  2001       Impact factor: 5.992

Review 3.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

4.  IgA-containing immune complexes in the circulation of patients with primary Sjögren's syndrome.

Authors:  B Bendaoud; Y L Pennec; A Lelong; J F Le Noac'h; G Magadur; J Jouquan; P Youinou
Journal:  J Autoimmun       Date:  1991-02       Impact factor: 7.094

5.  Sjögren's syndrome associated with haemolytic-uraemic syndrome as the presenting clinical manifestation.

Authors:  N Settefrati; M Bonomini; M Lodi; T D'Andrea; A Angelone; L Amoroso; P F Palmieri; A Albertazzi
Journal:  Nephrol Dial Transplant       Date:  1996-11       Impact factor: 5.992

6.  Cardiac manifestations in primary Sjögren's syndrome.

Authors:  M Gyöngyösi; G Pokorny; Z Jambrik; L Kovács; A Kovács; E Makula; M Csanády
Journal:  Ann Rheum Dis       Date:  1996-07       Impact factor: 19.103

Review 7.  Anti-SSA/Ro and anti-SSB/La antibody-mediated congenital heart block.

Authors:  N Costedoat-Chalumeau; S Georgin-Lavialle; Z Amoura; J C Piette
Journal:  Lupus       Date:  2005       Impact factor: 2.911

8.  Cytokine induction by circulating immune complexes and signs of in-vivo complement activation in systemic lupus erythematosus are associated with the occurrence of anti-Sjögren's syndrome A antibodies.

Authors:  L Mathsson; E Ahlin; C Sjöwall; T Skogh; J Rönnelid
Journal:  Clin Exp Immunol       Date:  2007-03       Impact factor: 4.330

9.  A study on the antigenic nature of circulating immune complexes in hemolytic uremic syndrome: no evidence of platelet membrane glycoprotein antigens.

Authors:  F Olavarria; J Pereira; S Mezzano; M Kunick; A Castillo
Journal:  Nephron       Date:  1994       Impact factor: 2.847

10.  Primary Sjögren's syndrome complicated by hemolytic uremic syndrome.

Authors:  E Agapitos; P M Pavlopoulos; G Vaiopoulos; P Davaris
Journal:  Scand J Rheumatol       Date:  1996       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.